TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils

被引:145
作者
Ajibade, Adebusola Alagbala [1 ,3 ]
Wang, Qinfu [1 ]
Cui, Jun [1 ,3 ]
Zou, Jia [1 ,3 ]
Xia, Xiaojun [1 ]
Wang, Mingjun [1 ,3 ]
Tong, Yanzheng [1 ,3 ]
Hui, Wei [1 ]
Liu, Dou [4 ]
Su, Bing [4 ]
Wang, Helen Y. [1 ,2 ,3 ]
Wang, Rong-Fu [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[3] Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA
[4] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
关键词
T-CELLS; RIG-I; INFLAMMATORY RESPONSES; INNATE; RECEPTOR; RECOGNITION; P38-ALPHA; HEPATOCYTES; INVOLVEMENT; INHIBITION;
D O I
10.1016/j.immuni.2011.12.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stringent control of NF-kappa B and mitogen-activated protein kinase (MAPK) signaling is critical during innate immune responses. TGF-beta activated kinase-1 (TAK1) is essential for NF-kappa B activation in T and B cells but has precisely the opposite activity in myeloid cells. Specific deletion of TAK1 (Map3k7(Delta M/Delta M)) led to development of splenomegaly and lymphomegaly associated with neutrophilia. Compared with wildtype cells, TAK1-deficient neutrophils enhanced the phosphorylation of the kinases IKK, p38, and JNK and the production of interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (INF-alpha), and reactive oxygen species (ROS) after lipopolysaccharide (LPS) stimulation. Map3k7(Delta M/Delta M) mice were significantly more susceptible to LPS-induced septic shock and produced higher amounts of IL-1 beta, IL-6, and TNF-alpha in plasma than do wild-type mice. Specific ablation of p38 rescued the phenotype and functional properties of Map3k7(Delta M/Delta M) mice. Our findings identify a previously unrecognized role of TAK1 as a negative regulator of p38 and IKK activation in a cell type-specific manner.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 48 条
  • [1] Ubiquitin-mediated activation of TAK1 and IKK
    Adhikari, A.
    Xu, M.
    Chen, Z. J.
    [J]. ONCOGENE, 2007, 26 (22) : 3214 - 3226
  • [2] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [3] NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways
    Allen, Irving C.
    Moore, Chris B.
    Schneider, Monika
    Lei, Yu
    Davis, Beckley K.
    Scull, Margaret A.
    Gris, Denis
    Roney, Kelly E.
    Zimmermann, Albert G.
    Bowzard, John B.
    Ranjan, Priya
    Monroe, Kathryn M.
    Pickles, Raymond J.
    Sambhara, Suryaprakash
    Ting, Jenny P. Y.
    [J]. IMMUNITY, 2011, 34 (06) : 854 - 865
  • [4] Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB
    Asehnoune, K
    Strassheim, D
    Mitra, S
    Kim, JY
    Abraham, E
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (04) : 2522 - 2529
  • [5] TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
    Bettermann, Kira
    Vucur, Mihael
    Haybaeck, Johannes
    Koppe, Christiane
    Janssen, Joern
    Heymann, Felix
    Weber, Achim
    Weiskirchen, Ralf
    Liedtke, Christian
    Gassler, Nikolaus
    Mueller, Michael
    de Vos, Rita
    Wolf, Monika Julia
    Boege, Yannick
    Seleznik, Gitta Maria
    Zeller, Nicolas
    Erny, Daniel
    Fuchs, Thomas
    Zoller, Stefan
    Cairo, Stefano
    Buendia, Marie-Annick
    Prinz, Marco
    Akira, Shizuo
    Tacke, Frank
    Heikenwalder, Mathias
    Trautwein, Christian
    Luedde, Tom
    [J]. CANCER CELL, 2010, 17 (05) : 481 - 496
  • [6] Ubiquitylation in innate and adaptive immunity
    Bhoj, Vijay G.
    Chen, Zhijian J.
    [J]. NATURE, 2009, 458 (7237) : 430 - 437
  • [7] The new bone biology: Pathologic, molecular, and clinical correlates
    Cohen, M. Michael, Jr.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (23) : 2646 - 2706
  • [8] NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
    Cui, Jun
    Zhu, Liang
    Xia, Xiaojun
    Wang, Helen Y.
    Legras, Xavier
    Hong, Jun
    Ji, Jiabing
    Shen, Pingping
    Zheng, Shu
    Chen, Zhijian J.
    Wang, Rong-Fu
    [J]. CELL, 2010, 141 (03) : 483 - 496
  • [9] P38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
    Engel, FB
    Schebesta, M
    Duong, MT
    Lu, G
    Ren, SX
    Madwed, JB
    Jiang, HP
    Wang, Y
    Keating, MT
    [J]. GENES & DEVELOPMENT, 2005, 19 (10) : 1175 - 1187
  • [10] MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α
    Ge, BX
    Gram, H
    Di Padova, F
    Huang, B
    New, L
    Ulevitch, RJ
    Luo, Y
    Han, JH
    [J]. SCIENCE, 2002, 295 (5558) : 1291 - 1294